Chris Froome cleared of doping charges and free to race Tour de France

Joe Robinson 2 Jul 2018 UCI clears Froome of adverse analytical finding of salbutamol just days before the start of the Tour de France Chris Froome (Team Sky) has been cleared by the UCI for his adverse analytical finding for salbutamol, meaning he is clear to start the Tour de France this Saturday in the Vendee Region of France. The decision also means Froome will keep his Vuelta a Espana and Giro d'Italia titles, with the UCI saying it has closed all investigations into the matter. A press release from the UCI this morning concluded that 'anti-doping proceedings involving Mr Christopher Froome have now been closed'. 'The UCI has considered all the relevant evidence in detail (in consultation with its own experts and experts from WADA). On 28 June 2018, WADA informed the UCI that it would accept, based on the specific facts of the case, that Mr Froome’s sample ...
More Like This

UCI responds to criticism surrounding Chris Froome judgement

WADA decides against Froome anti-doping appeal

UCI closes salbutamol case against Chris Froome

Lappartient says UCI had to follow WADA’s lead and clear Froome

Clearing Chris Froome lacks credibility without providing evidence, says anti-doping expert

UCI drops investigation into Froome, says it accepts no rules were broken in Salbutamol case

UCI says no reasoned decision will be released for Froome case, elaborates on related topics

'It means we can all move on': Team Sky and Froome react to UCI verdict

Analysis: WADA appears to contradict UCI over Froome case decision
